AstraZeneca unveiled its new Discovery Centre (DISC) in Cambridge, UK, a new, £1 billion state-of-the-art R&D facility designed to the highest environmental standards and accommodating more than 2,200 research scientists.   The new facility will include advanced robotics, high-throughput screening and AI-driven technology. It will support AZ’s focus on specialized and precision medicines and foster the discovery and development of next generation therapeutics, including nucleotide-based, g...